I'll be happy with 100 kids treated and saved p.a. ... still a huge EBITA in comparison to our current EBITA... and then of course there's the adults and off label indications .... "Sell / Not Held" says the Doc .... let's see how that goes today ? LMAO
You forgot to tell us "it wont sell" .... hehe
You're also discounting license fees in your assessment of revenues for any big pharma that wants to step up in the IBD / Crohn's market so there is that
It is good to see the stock you have raved about for years getting pummeled and brought back down to reality ... must be getting close to a buy at around $1 if it gets there or under again ?
Have a great day !
MSB Price at posting:
$2.71 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)